poisar

Stocks · News reference

HC Wainwright & Co. Downgrades TScan Therapeutics to Neutral, Lowers Price Target to $1

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

TCRX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — TScan Therapeutics, Inc. (TCRX)

    Filed: 2026-09-11 AccNo: 0001193125-26-388631 Size: 143 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    TCRX